Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix

Journal of Virology

Volumn 84, Issue 1, 2010, Pages 503-515

  Hamard Peron, E ^a   Juillard, F ^a   Saad, J S ^b,e   Roy, C ^c   Roingeard, P ^d   Summers, M F ^b   Darlix, J L ^a   Picart, C ^c,f   Muriaux, D ^a  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^c CNRS   (France)

^d UNIVERSITÉ DE TOURS   (France)

^e University of Alabama at Birmingham   (United States)

^f LABORATOIRE DES MATÉRIAUX ET DU GÉNIE PHYSIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHATIDYLSERINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IN VITRO STUDY; MATRIX ATTACHMENT REGION; MEMBRANE BINDING; MURINE LEUKEMIA VIRUS; MUTANT; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RETROVIRUS; VIRUS MORPHOLOGY;

BINDING SITES; CELL MEMBRANE; GENE PRODUCTS, GAG; LEUKEMIA VIRUS, MURINE; MUTAGENESIS; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHATIDYLSERINES; RETROVIRIDAE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; MURINE LEUKEMIA VIRUS;

EID: 72849142782     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01134-09     Document Type: Article

References (63)

1. Alfadhli, A., R. L. Barklis, and E. Barklis. 2009. HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)- bisphosphate. Virology 387:466-472.
2. Andrawiss, M., Y. Takeuchi, L. Hewlett, and M. Collins. 2003. Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association. J. Virol. 77:11651-11660. (Pubitemid 37271664)
3. Basyuk, E., T. Galli, M. Mougel, J. Blanchard, M. Sitbon, and E. Bertrand. 2003. Retroviral genomic RNAs are transported to the plasma membrane by endosomal vesicles. Dev. Cell 5:161-174. (Pubitemid 36827350)
4. Blin, G., E. Margeat, K. Carvalho, C. A. Royer, C. Roy, and C. Picart. 2008. Quantitative analysis of the binding of ezrin to large unilamellar vesicles containing phosphatidylinositol 4,5 bisphosphate. Biophys. J. 94:1021-1033. (Pubitemid 351162465)
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Bryant, M., and L. Ratner. 1990. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. U. S. A. 87:523-527.
7. Camus, G., C. Segura-Morales, D. Molle, S. Lopez-Vergés, C. Begon-Pescia, C. Cazevieille, P. Schu, E. Bertrand, C. Berlioz-Torrent, and E. Basyuk. 2007. The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding. Mol. Biol. Cell 18:3193-3203.
8. Cantor, C., and P. Schimmel. 1998. Biophysical chemistry. Freeman, New York, NY.
9. Chan, R., P. D. Uchil, J. Jin, G. Shui, D. E. Ott, W. Mothes, and M. R. Wenk. 2008. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 82:11228-11238.
10. Chan, W., N. M. Sherer, P. D. Uchil, E. K. Novak, R. T. Swank, and W. Mothes. 2008. Murine leukemia virus spreading in mice impaired in the biogenesis of secretory lysosomes and CA2+-regulated exocytosis. PLoS One 3:e2713.
11. Chen, B. K., I. Rousso, S. Shim, and P. S. Kim. 2001. Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells. Proc. Natl. Acad. Sci. U. S. A. 98:15239-15244.
12. Chen, K., I. Bachtiar, G. Piszczek, F. Bouamr, C. Carter, and N. Tjandra. 2008. Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2. Biochemistry 47:1928-1937. (Pubitemid 351287118)
13. Chukkapalli, V., I. B. Hogue, V. Boyko, W. Hu, and A. Ono. 2008. Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient Gag membrane binding. J. Virol. 82:2405-2417.
14. Coffin, J., S. Hughes, and H. Varmus. 1997. Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
15. Conte, M. R., and S. Matthews. 1998. Retroviral matrix proteins: a structural perspective. Virology 246:191-198.
16. Dalton, A. K., D. Ako-Adjei, P. S. Murray, D. Murray, and V. M. Vogt. 2007. Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain. J. Virol. 81:6434-6445. (Pubitemid 46878049)
17. Dalton, A. K., P. S. Murray, D. Murray, and V. M. Vogt. 2005. Biochemical characterization of Rous sarcoma virus MA protein interaction with membranes. J. Virol. 79:6227-6238. (Pubitemid 40617227)
18. Darlix, J. L., M. Lapadat-Tapolsky, H. de Rocquigny, and B. P. Roques. 1995. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254:523-537.
19. Datta, S. A. K., Z. Zhao, P. K. Clark, S. Tarasov, J. N. Alexandratos, S. J. Campbell, M. Kvaratskhelia, J. Lebowitz, and A. Rein. 2007. Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J. Mol. Biol. 365:799-811.
20. Di Paolo, G., and P. De Camilli. 2006. Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651-657. (Pubitemid 44564702)
21. Göttlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U. S. A. 86:5781-5785.
22. Gousset, K., S. D. Ablan, L. V. Coren, A. Ono, F. Soheilian, K. Nagashima, D. E. Ott, and E. O. Freed. 2008. Real-time visualization of HIV-1 Gag trafficking in infected macrophages. PLoS Pathog. 4:e1000015.
23. Granowitz, C., and S. P. Goff. 1994. Substitution mutations affecting a small region of the Moloney murine leukemia virus MA Gag protein block assembly and release of virion particles. Virology 205:336-344. (Pubitemid 24360621)
24. Grigorov, B., F. Arcanger, P. Roingeard, J. Darlix, and D. Muriaux. 2006. Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines. J. Mol. Biol. 359:848-862.
25. Hansen, M., L. Jelinek, S. Whiting, and E. Barklis. 1990. Transport and assembly of Gag proteins into Moloney murine leukemia virus. J. Virol. 64:5306-5316. (Pubitemid 20364520)
26. Hermida-Matsumoto, L., and M. D. Resh. 1999. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of pr55gag and p17MA. J. Virol. 73:1902-1908. (Pubitemid 29098091)
27. Hokanson, D. E., J. M. Laakso, T. Lin, D. Sept, and E. M. Ostap. 2006. Myo1c binds phosphoinositides through a putative pleckstrin homology domain. Mol. Biol. Cell 17:4856-4865.
28. Houzet, L., B. Gay, Z. Morichaud, L. Briant, and M. Mougel. 2006. Intracellular assembly and budding of the murine leukemia virus in infected cells. Retrovirology 3:12.
29. Jin, J., N. M. Sherer, G. Heidecker, D. Derse, and W. Mothes. 2009. Assembly of the murine leukemia virus is directed towards sites of cell-cell contact. PLoS Biol. 7:e1000163.
30. Krauss, M., and V. Haucke. 2007. Phosphoinositides: regulators of membrane traffic and protein function. FEBS Lett. 581:2105-2111. (Pubitemid 46709898)
31. Krauss, M., and V. Haucke. 2007. Phosphoinositide-metabolizing enzymes at the interface between membrane traffic and cell signalling. EMBO Rep. 8:241-246. (Pubitemid 46344588)
32. Leung, J., A. Yueh, F. S. K. J. Appah, B. Yuan, K. de los Santos, and S. P. Goff. 2006. Interaction of Moloney murine leukemia virus matrix protein with IQGAP. EMBO J. 25:2155-2166.
33. Low, M. G., and J. B. Finean. 1977. Modification of erythrocyte membranes by a purified phosphatidylinositol-specific phospholipase C (Staphylococcus aureus). Biochem. J. 162:235-240.
34. Manna, D., N. Bhardwaj, M. S. Vora, R. V. Stahelin, H. Lu, and W. Cho. 2008. Differential roles of phosphatidylserine, PtdIns(4,5)P2, and PtdIns(3,4,5)P3 in plasma membrane targeting of C2 domains. Molecular dynamics simulation, membrane binding, and cell translocation studies of the PKCalpha C2 domain. J. Biol. Chem. 283:26047-26058.
35. Muriaux, D., J. L. Darlix, and A. Cimarelli. 2004. Targeting the assembly of the human immunodeficiency virus type I. Curr. Pharm. Des. 10:3725-3739.
36. Muriaux, D., S. Costes, K. Nagashima, J. Mirro, E. Cho, S. Lockett, and A. Rein. 2004. Role of murine leukemia virus nucleocapsid protein in virus assembly. J. Virol. 78:12378-12385. (Pubitemid 39458756)
37. Murray, P. S., Z. Li, J. Wang, C. L. Tang, B. Honig, and D. Murray. 2005. Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle. Structure 13:1521-1531.
38. Ono, A., and E. O. Freed. 2004. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J. Virol. 78:1552-1563.
39. Ono, A., and E. O. Freed. 1999. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73:4136-4144.
40. Ono, A., S. D. Ablan, S. J. Lockett, K. Nagashima, and E. O. Freed. 2004. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 101:14889-14894.
41. Paillart, J. C., and H. G. Göttlinger. 1999. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of Gag membrane targeting. J. Virol. 73:2604-2612.
42. Raposo, G., M. Moore, D. Innes, R. Leijendekker, A. Leigh-Brown, P. Benaroch, and H. Geuze. 2002. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3:718-729.
43. Reed, M., R. Mariani, L. Sheppard, K. Pekrun, N. R. Landau, and N. Soong. 2002. Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells. J. Virol. 76:436-443. (Pubitemid 33139031)
44. Rein, A. 1994. Retroviral RNA packaging: a review. Arch. Virol. Suppl. 9:513-522.
45. Rein, A., M. R. McClure, N. R. Rice, R. B. Luftig, and A. M. Schultz. 1986. Myristylation site in pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. U. S. A. 83:7246-7250.
46. Resh, M. D. 2004. A myristoyl switch regulates membrane binding of HIV-1 Gag. Proc. Natl. Acad. Sci. U. S. A. 101:417-418.
47. Riffel, N., K. Harlos, O. Iourin, Z. Rao, A. Kingsman, D. Stuart, and E. Fry. 2002. Atomic resolution structure of Moloney murine leukemia virus matrix protein and its relationship to other retroviral matrix proteins. Structure 10:1627-1636. (Pubitemid 35447977)
48. Saad, J. S., E. Loeliger, P. Luncsford, M. Liriano, J. Tai, A. Kim, J. Miller, A. Joshi, E. O. Freed, and M. F. Summers. 2007. Point mutations in the HIV-1 matrix protein turn off the myristyl switch. J. Mol. Biol. 366:574-585.
49. Saad, J. S., J. Miller, J. Tai, A. Kim, R. H. Ghanam, and M. F. Summers. 2006. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. U. S. A. 103:11364-11369.
50. Saad, J. S., S. D. Ablan, R. H. Ghanam, A. Kim, K. Andrews, K. Nagashima, F. Soheilian, E. O. Freed, and M. F. Summers. 2008. Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting. J. Mol. Biol. 382:434-447.
51. Sandrin, V., D. Muriaux, J. Darlix, and F. Cosset. 2004. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. J. Virol. 78:7153-7164. (Pubitemid 38781554)
52. Sherer, N. M., M. J. Lehmann, L. F. Jimenez-Soto, A. Ingmundson, S. M. Horner, G. Cicchetti, P. G. Allen, M. Pypaert, J. M. Cunningham, and W. Mothes. 2003. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4:785-801.
53. Soneoka, Y., S. M. Kingsman, and A. J. Kingsman. 1997. Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport. J. Virol. 71:5549-5559. (Pubitemid 27258234)
54. Spearman, P., R. Horton, L. Ratner, and I. Kuli-Zade. 1997. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 71:6582-6592. (Pubitemid 27355316)
55. Suomalainen, M., K. Hultenby, and H. Garoff. 1996. Targeting of Moloney murine leukemia virus Gag precursor to the site of virus budding. J. Cell Biol. 135:1841-1852. (Pubitemid 27036445)
56. Tang, C., E. Loeliger, P. Luncsford, I. Kinde, D. Beckett, and M. F. Summers. 2004. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl. Acad. Sci. U. S. A. 101:517-522.
57. Wang, C. T., and E. Barklis. 1993. Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J. Virol. 67:4264-4273. (Pubitemid 23180753)
58. Yu, Q., and J. L. Darlix. 1996. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo. J. Virol. 70:5791-5798. (Pubitemid 26266787)
59. Yu, Z., C. Beer, M. Koester, and M. Wirth. 2006. Caveolin-1 interacts with the Gag precursor of murine leukaemia virus and modulates virus production. Virol. J. 3:73. (Pubitemid 44449055)
60. Yuan, B., X. Li, and S. P. Goff. 1999. Mutations altering the Moloney murine leukemia virus p12 gag protein affect virion production and early events of the virus life cycle. EMBO J. 18:4700-4710. (Pubitemid 29415524)
61. Yuan, X., X. Yu, T. H. Lee, and M. Essex. 1993. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 67:6387-6394.
62. Zhou, W., and M. D. Resh. 1996. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70:8540-8548. (Pubitemid 26378433)
63. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh. 1994. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569. (Pubitemid 24091935)